Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.21B |
| 2 |
Apple
AAPL
|
+$1.07B |
| 3 |
UnitedHealth
UNH
|
+$937M |
| 4 |
Broadcom
AVGO
|
+$737M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$608M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.25B |
| 3 |
Royal Bank of Canada
RY
|
+$1.15B |
| 4 |
TC Energy
TRP
|
+$1.11B |
| 5 |
Amazon
AMZN
|
+$969M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Financials | 8.69% |
| 3 | Consumer Discretionary | 7.16% |
| 4 | Healthcare | 6.71% |
| 5 | Communication Services | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5801
Shimmick
SHIM
$168M
| $33.2K | ﹤0.01% |
+12,814
| New | +$30.7K |
|
5802
Neuronetics
STIM
$150M
| $32.8K | ﹤0.01% |
+20,379
| New | +$21.2K |
|
5803
CervoMed
CRVO
$24.1M
| $32.2K | ﹤0.01% |
+13,750
| New | +$134K |
|
5804
Falcon's Beyond Global Warrants
FBYDW
$10.3M
| $31K | ﹤0.01% |
50,000
| – | – |
|
|
NBTX
5805
Nanobiotix
NBTX
$1.98B
| $30.1K | ﹤0.01% |
+10,498
| New | +$42K |
|
5806
Aterian
ATER
$4.76M
| $29.7K | ﹤0.01% |
+12,366
| New | +$32.8K |
|
5807
Vor Biopharma
VOR
$1.16B
| $29.6K | ﹤0.01% |
1,335
-76
| -5% | -$1.26K |
|
|
CLSKW
5808
CleanSpark Inc Warrant
CLSKW
$303K
| $28.5K | ﹤0.01% |
+39,595
| New | +$32.6K |
|
|
SOL
5809
DELISTED
Emeren Group
SOL
| $28.5K | ﹤0.01% |
14,017
-16,434
| -54% | -$36.3K |
|
|
MRNS
5810
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $28K | ﹤0.01% |
52,328
+12,251
| +31% | +$8.54K |
|
|
AMRN
5811
Amarin Corp
AMRN
$297M
| $27.4K | ﹤0.01% |
2,825
-757
| -21% | -$8.11K |
|
|
ZEOWW
5812
Zeo Energy Corp Warrants
ZEOWW
$155K
| $26.8K | ﹤0.01% |
256,875
| – | – |
|
5813
Bolt Biotherapeutics
BOLT
$7.65M
| $26.8K | ﹤0.01% |
+2,501
| New | +$30.2K |
|
5814
Fortress Biotech
FBIO
$91.7M
| $26K | ﹤0.01% |
+12,837
| New | +$23.3K |
|
5815
CuriosityStream
CURI
$150M
| $25.4K | ﹤0.01% |
+16,605
| New | +$32K |
|
|
MGRM
5816
DELISTED
Monogram Orthopaedics
MGRM
| $25.4K | ﹤0.01% |
+10,712
| New | +$25.1K |
|
|
YYGH
5817
YY Group Holding Ltd
YYGH
$3.94M
| $24.6K | ﹤0.01% |
+9
| New | +$22.2K |
|
|
ALLR
5818
Allarity Therapeutics
ALLR
$20.2M
| $24.1K | ﹤0.01% |
+20,616
| New | +$27.3K |
|
|
KYNB
5819
Kyntra Bio
KYNB
$27.4M
| $24K | ﹤0.01% |
1,812
-251
| -12% | -$2.33K |
|
5820
Battalion Oil
BATL
$31M
| $23.8K | ﹤0.01% |
13,815
+476
| +4% | +$2.32K |
|
|
DHY
5821
Credit Suisse High Yield Credit Fund
DHY
$239M
| $22.9K | ﹤0.01% |
+10,700
| New | +$23.5K |
|
5822
Cytosorbents Corp
CTSO
$23.1M
| $22.9K | ﹤0.01% |
+25,143
| New | +$24.7K |
|
5823
Rafael Holdings
RFL
$104M
| $22.8K | ﹤0.01% |
+13,999
| New | +$26.3K |
|
5824
Genprex
GNPX
$2.4M
| $22.5K | ﹤0.01% |
+24
| New | +$31.5K |
|
5825
IGC Pharma
IGC
$25.6M
| $22K | ﹤0.01% |
65,541
| – | – |
|
Similar funds
Goldman Sachs's Q4 2024 Portfolio in Review
As of Q4 2024, Goldman Sachs held 6,412 positions worth $634B, up 2.1% from $621B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Goldman Sachs's Q4 2024 filing shows 625 new, 2,947 increased, 1,944 reduced and 418 closed positions. Its largest new stake was iShares Ethereum Trust ETF: 9,312,244 shares worth $236M. The largest sale was iShares Russell 2000 ETF, an estimated $1.41B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Goldman Sachs's largest Q4 2024 buy was iShares Ethereum Trust ETF: 9,312,244 shares worth $236M.
- Goldman Sachs added most to Meta Platforms (Facebook) in Q4 2024, an estimated $1.21B increase.
- Goldman Sachs's biggest Q4 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $1.41B.
- Goldman Sachs fully exited Sterling Check Corp. Common Stock in Q4 2024, selling an estimated $833M.
- Goldman Sachs's ten largest holdings make up 21% of its $634B portfolio in Q4 2024.
- Goldman Sachs opened 625 new positions and closed 418 in Q4 2024.
- Goldman Sachs's portfolio value rose 2.1% quarter-over-quarter to $634B.
Based on Goldman Sachs's 13F filing for Q4 2024, filed 11 Feb 2025.